SPARSH BIOTECH is confidently establishing itself as a key player in the pharmaceutical sector, particularly recognized for its innovative process of manufacturing Amoxicillin and Augmentin. The organization boasts state-of-the-art infrastructure and a focused team ensuring excellent antibiotics serving patients international